Abstract
In a selected group of 207 breast cancer patients with tumor-free axillary nodes, clinical and pathological features were evaluated as to their relationship to long-term disease-free survival. No clinical feature was found to be prognostically useful. Of pathologic features studied, four appear to have significance. These are (1) the volume of the primary mass, (2) the histologic or nuclear grade, (3) the presence of invasive lobular carcinoma in the primary mass, and possibly (4) the presence of neoplastic cells in intramammary lymphatic vessels. When two or more of these four features are present, prognosis is less favorable than when there is only one, but the influences are not arithmetically additive.
References
Bonadonna G, Valagussa P: Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10–15, 1981
Fisher B, Redmond C, Wolmark N, Wieand S: Diseasefree survival at intervals during and following completion of adjuvant chemotherapy. The NSABP experience from three breast cancer protocols. Cancer 49: 1273–1280, 1981
White EC, Fletcher GH, Clark RL: Surgical experience with preoperative irradiation for carcinoma of the breast. Ann Surg 155: 942–953, 1962
Gallager HS: Minimal breast cancer concepts and results of treatment. Clinics in Oncology 1: 389–399, 1982
de Waard F: Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35: 3351–3356, 1975
Hartman WH, Ozzello L, Sobin HL, Stalsbert H (eds): Histological Typing of Breast Tumours, 2nd edition. World Health Organization, Geneva, 1981
Bloom HJG, Richardson WW: Histologic grading and prognosis in breast cancer. A study of 1409 cases in which 359 have been followed 15 years. Br J Cancer 11: 359–377, 1957
Black MM, Speer FD: Nuclear structure in cancer tissues. Surg Gynecol Obstet 105: 97–102, 1957
Berkson J, Gage RP: Survival curve for cancer patients following treatment. J Am Stat Assoc 47: 501–515, 1952
Gehan EA: A generalized Wilcoxon test for comparing arbitrarily single censored samples. Biometrika 52: 203–223, 1965
Nealon Jr TF, Nkongho A, Grassi C, Gillooley J: Pathologic identification for poor prognosis. Stage I (T1N0M0) cancer of the breast. Ann Surg 190: 129–132, 1979
Rosen PP, Saigo PE, Braun Jr DW, Weathers E, DePalo A: Predictors of recurrence in Stage I (T1N0M0) breast cancer. Ann Surg 193: 15–25, 1981
Baker LH: Breast Cancer Detection Demonstration Project: Five year summary report. CA A Journal for Clinicians 32: 194–225, 1982
Kushner R: Alternatives. Kensington Press, Cambridge, MA, 1984
Alderson MR, Hamlin I, Staunton MD: The relative significance of prognostic factors in breast cancer. Br J Cancer 25: 646–656, 1971
Ariel IM: Results of treating 1178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred. J Surg Oncol 12: 137–153, 1979
Fisher ER, Redmond C, Fisher B: Pathological findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) VI. Discriminants for five-year treatment failure. Cancer 46: 908–918, 1980
Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41: 1170–1178, 1978
Newman W: Lobular carcinoma of the female breast. Ann Surg 164: 305–314, 1966
Fisher ER: The pathologist's role in the diagnosis and treatment of invasive breast cancer. Surg Clin North Am 59: 705–721, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van de Velde, C.J.H., Stephen Gallager, H. & Giacco, G.G. Prognosis in node-negative breast cancer. Breast Cancer Res Tr 8, 189–196 (1986). https://doi.org/10.1007/BF01807331
Issue Date:
DOI: https://doi.org/10.1007/BF01807331